Submitted by Anonymous (not verified) on 23 May 2025 - 15:38
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised